| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription corepressor activity | 8.71e-07 | 229 | 46 | 7 | GO:0003714 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.71e-05 | 22 | 46 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 2.24e-05 | 24 | 46 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.81e-05 | 562 | 46 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 4.92e-05 | 1160 | 46 | 11 | GO:0030674 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 1.08e-04 | 7 | 46 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.99e-04 | 1356 | 46 | 11 | GO:0060090 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 1.03e-03 | 337 | 46 | 5 | GO:0001664 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 1.16e-03 | 22 | 46 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 1.37e-03 | 95 | 46 | 3 | GO:0005546 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 1.39e-03 | 24 | 46 | 2 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 1.51e-03 | 25 | 46 | 2 | GO:0004114 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 1.63e-03 | 26 | 46 | 2 | GO:0050780 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.76e-03 | 27 | 46 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 2.72e-03 | 121 | 46 | 3 | GO:1902936 | |
| GeneOntologyMolecularFunction | fibronectin binding | 3.46e-03 | 38 | 46 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 3.64e-03 | 39 | 46 | 2 | GO:0031369 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.84e-03 | 279 | 46 | 4 | GO:0005096 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane organization | 9.33e-08 | 20 | 45 | 4 | GO:1903729 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 8.01e-07 | 239 | 45 | 7 | GO:0031032 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 1.58e-06 | 11 | 45 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 3.52e-06 | 191 | 45 | 6 | GO:0051017 | |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 3.96e-06 | 195 | 45 | 6 | GO:0061572 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 4.34e-06 | 15 | 45 | 3 | GO:0070142 | |
| GeneOntologyBiologicalProcess | negative regulation of vasoconstriction | 7.74e-06 | 18 | 45 | 3 | GO:0045906 | |
| GeneOntologyBiologicalProcess | vesicle scission | 1.39e-05 | 3 | 45 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ASAP3 ARHGAP28 HSP90B1 MYH9 KLHL41 NEB TUBGCP5 ITGB1 DNM2 ANKRD53 | 3.20e-05 | 957 | 45 | 10 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 5.03e-05 | 618 | 45 | 8 | GO:0090066 | |
| GeneOntologyBiologicalProcess | regulation of membrane tubulation | 6.94e-05 | 6 | 45 | 2 | GO:1903525 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | 8.85e-05 | 670 | 45 | 8 | GO:0120031 | |
| GeneOntologyBiologicalProcess | cell projection assembly | 1.03e-04 | 685 | 45 | 8 | GO:0030031 | |
| GeneOntologyBiologicalProcess | actin filament organization | 1.08e-04 | 509 | 45 | 7 | GO:0007015 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 1.68e-04 | 127 | 45 | 4 | GO:0030038 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 1.68e-04 | 127 | 45 | 4 | GO:0043149 | |
| GeneOntologyBiologicalProcess | synaptic vesicle transport | 2.23e-04 | 54 | 45 | 3 | GO:0048489 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 2.75e-04 | 58 | 45 | 3 | GO:0007520 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 3.06e-04 | 803 | 45 | 8 | GO:0030036 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 3.10e-04 | 149 | 45 | 4 | GO:0010811 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 3.96e-04 | 1058 | 45 | 9 | GO:0007017 | |
| GeneOntologyBiologicalProcess | formation of cytoplasmic translation initiation complex | 4.80e-04 | 15 | 45 | 2 | GO:0001732 | |
| GeneOntologyBiologicalProcess | intraciliary retrograde transport | 4.80e-04 | 15 | 45 | 2 | GO:0035721 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 5.00e-04 | 71 | 45 | 3 | GO:0097479 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle recycling | 6.20e-04 | 17 | 45 | 2 | GO:1903423 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 6.34e-04 | 77 | 45 | 3 | GO:0061512 | |
| GeneOntologyBiologicalProcess | regulation of G protein-coupled receptor signaling pathway | 6.45e-04 | 181 | 45 | 4 | GO:0008277 | |
| GeneOntologyBiologicalProcess | receptor internalization | 6.59e-04 | 182 | 45 | 4 | GO:0031623 | |
| GeneOntologyBiologicalProcess | organelle assembly | 6.72e-04 | 1138 | 45 | 9 | GO:0070925 | |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine development | 6.96e-04 | 18 | 45 | 2 | GO:0061000 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 7.12e-04 | 912 | 45 | 8 | GO:0030029 | |
| GeneOntologyBiologicalProcess | membrane organization | 7.22e-04 | 914 | 45 | 8 | GO:0061024 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 7.44e-04 | 188 | 45 | 4 | GO:0007009 | |
| GeneOntologyBiologicalProcess | protein polymerization | 7.76e-04 | 334 | 45 | 5 | GO:0051258 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 8.46e-04 | 85 | 45 | 3 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 8.46e-04 | 85 | 45 | 3 | GO:0000768 | |
| GeneOntologyBiologicalProcess | plasma membrane tubulation | 8.62e-04 | 20 | 45 | 2 | GO:0097320 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 8.75e-04 | 86 | 45 | 3 | GO:0030239 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 8.76e-04 | 720 | 45 | 7 | GO:0000226 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor internalization | 9.52e-04 | 21 | 45 | 2 | GO:0002031 | |
| GeneOntologyBiologicalProcess | syncytium formation | 9.67e-04 | 89 | 45 | 3 | GO:0006949 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 9.67e-04 | 89 | 45 | 3 | GO:0055002 | |
| GeneOntologyBiologicalProcess | vesicle budding from membrane | 1.03e-03 | 91 | 45 | 3 | GO:0006900 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | 1.13e-03 | 546 | 45 | 6 | GO:0051656 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 1.18e-03 | 213 | 45 | 4 | GO:0045807 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 1.20e-03 | 96 | 45 | 3 | GO:0048488 | |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 1.28e-03 | 98 | 45 | 3 | GO:0019229 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 1.43e-03 | 102 | 45 | 3 | GO:0140238 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 1.56e-03 | 391 | 45 | 5 | GO:0051146 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 1.83e-03 | 111 | 45 | 3 | GO:0036465 | |
| GeneOntologyCellularComponent | sperm flagellum | 6.72e-10 | 214 | 45 | 9 | GO:0036126 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.71e-09 | 238 | 45 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | cilium | CFAP58 CILK1 SSX9P SSX6P SSX7 SSX8P PDE6A SSX1 USP48 SSX3 SSX5 FLACC1 TTC21A | 3.17e-08 | 898 | 45 | 13 | GO:0005929 |
| GeneOntologyCellularComponent | motile cilium | 5.49e-08 | 355 | 45 | 9 | GO:0031514 | |
| GeneOntologyCellularComponent | ruffle | 7.85e-05 | 206 | 45 | 5 | GO:0001726 | |
| GeneOntologyCellularComponent | podosome | 9.38e-05 | 41 | 45 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | dynactin complex | 1.26e-04 | 8 | 45 | 2 | GO:0005869 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 1.62e-04 | 9 | 45 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 2.13e-04 | 576 | 45 | 7 | GO:0015629 | |
| GeneOntologyCellularComponent | uropod | 4.06e-04 | 14 | 45 | 2 | GO:0001931 | |
| GeneOntologyCellularComponent | cell trailing edge | 4.67e-04 | 15 | 45 | 2 | GO:0031254 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 5.33e-04 | 16 | 45 | 2 | GO:0005852 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 6.33e-04 | 78 | 45 | 3 | GO:0001917 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 6.78e-04 | 18 | 45 | 2 | GO:0033290 | |
| GeneOntologyCellularComponent | cell division site | 6.82e-04 | 80 | 45 | 3 | GO:0032153 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 7.57e-04 | 19 | 45 | 2 | GO:0016282 | |
| GeneOntologyCellularComponent | supramolecular fiber | 7.87e-04 | 1179 | 45 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 8.26e-04 | 1187 | 45 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 8.40e-04 | 20 | 45 | 2 | GO:0070993 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.36e-03 | 384 | 45 | 5 | GO:0030139 | |
| GeneOntologyCellularComponent | focal adhesion | 2.26e-03 | 431 | 45 | 5 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 2.54e-03 | 443 | 45 | 5 | GO:0030055 | |
| GeneOntologyCellularComponent | microtubule organizing center | 3.27e-03 | 919 | 45 | 7 | GO:0005815 | |
| GeneOntologyCellularComponent | cell leading edge | 4.26e-03 | 500 | 45 | 5 | GO:0031252 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 4.68e-03 | 157 | 45 | 3 | GO:0045335 | |
| GeneOntologyCellularComponent | centrosome | 5.86e-03 | 770 | 45 | 6 | GO:0005813 | |
| GeneOntologyCellularComponent | centriole | 6.03e-03 | 172 | 45 | 3 | GO:0005814 | |
| GeneOntologyCellularComponent | cleavage furrow | 7.65e-03 | 61 | 45 | 2 | GO:0032154 | |
| GeneOntologyCellularComponent | synaptic membrane | 8.08e-03 | 583 | 45 | 5 | GO:0097060 | |
| MousePheno | abnormal hallux morphology | 4.74e-05 | 5 | 31 | 2 | MP:0009049 | |
| MousePheno | belly spot | 9.94e-05 | 41 | 31 | 3 | MP:0000373 | |
| MousePheno | white spotting | 1.80e-04 | 50 | 31 | 3 | MP:0002938 | |
| MousePheno | abnormal autopod morphology | 1.85e-04 | 390 | 31 | 6 | MP:0000572 | |
| MousePheno | head spot | 2.12e-04 | 10 | 31 | 2 | MP:0002939 | |
| MousePheno | abnormal limb morphology | 2.79e-04 | 1028 | 31 | 9 | MP:0002109 | |
| MousePheno | abnormal coat/hair pigmentation | 2.90e-04 | 424 | 31 | 6 | MP:0002075 | |
| Domain | KRAB_RELATED | 7.93e-20 | 11 | 44 | 8 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 6.17e-19 | 13 | 44 | 8 | IPR003655 | |
| Domain | SSX | 3.44e-13 | 6 | 44 | 5 | IPR028804 | |
| Domain | SSXRD | 3.20e-12 | 8 | 44 | 5 | PF09514 | |
| Domain | SSXRD_motif | 3.20e-12 | 8 | 44 | 5 | IPR019041 | |
| Domain | Dynamin_central | 2.43e-07 | 6 | 44 | 3 | IPR000375 | |
| Domain | Dynamin_M | 2.43e-07 | 6 | 44 | 3 | PF01031 | |
| Domain | Dynamin_GTPase_CS | 2.43e-07 | 6 | 44 | 3 | IPR019762 | |
| Domain | GED | 2.43e-07 | 6 | 44 | 3 | SM00302 | |
| Domain | GED_dom | 2.43e-07 | 6 | 44 | 3 | IPR020850 | |
| Domain | GED | 2.43e-07 | 6 | 44 | 3 | PF02212 | |
| Domain | GED | 2.43e-07 | 6 | 44 | 3 | IPR003130 | |
| Domain | GED | 2.43e-07 | 6 | 44 | 3 | PS51388 | |
| Domain | G_DYNAMIN_1 | 4.24e-07 | 7 | 44 | 3 | PS00410 | |
| Domain | DYNc | 4.24e-07 | 7 | 44 | 3 | SM00053 | |
| Domain | KRAB | 2.05e-06 | 369 | 44 | 8 | SM00349 | |
| Domain | KRAB | 2.09e-06 | 370 | 44 | 8 | IPR001909 | |
| Domain | G_DYNAMIN_dom | 4.36e-06 | 14 | 44 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 4.36e-06 | 14 | 44 | 3 | PS51718 | |
| Domain | Arp1 | 5.42e-06 | 2 | 44 | 2 | IPR029909 | |
| Domain | EIF3C_N_dom | 5.42e-06 | 2 | 44 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 5.42e-06 | 2 | 44 | 2 | PF05470 | |
| Domain | EIF3C | 5.42e-06 | 2 | 44 | 2 | IPR027516 | |
| Domain | Dynamin_SF | 5.44e-06 | 15 | 44 | 3 | IPR022812 | |
| Domain | Dynamin_GTPase | 5.44e-06 | 15 | 44 | 3 | IPR001401 | |
| Domain | Dynamin_N | 5.44e-06 | 15 | 44 | 3 | PF00350 | |
| Domain | GAF | 1.13e-04 | 7 | 44 | 2 | PF01590 | |
| Domain | GAF | 1.51e-04 | 8 | 44 | 2 | IPR003018 | |
| Domain | GAF | 1.51e-04 | 8 | 44 | 2 | SM00065 | |
| Domain | - | 1.93e-04 | 9 | 44 | 2 | 3.30.450.40 | |
| Domain | GAF_dom-like | 1.93e-04 | 9 | 44 | 2 | IPR029016 | |
| Domain | PH | 1.95e-04 | 229 | 44 | 5 | PF00169 | |
| Domain | PH | 4.76e-04 | 278 | 44 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 4.84e-04 | 279 | 44 | 5 | PS50003 | |
| Domain | PH_domain | 4.92e-04 | 280 | 44 | 5 | IPR001849 | |
| Domain | SH3_1 | 5.92e-04 | 164 | 44 | 4 | PF00018 | |
| Domain | Actin_CS | 6.37e-04 | 16 | 44 | 2 | IPR004001 | |
| Domain | PINT | 6.37e-04 | 16 | 44 | 2 | SM00088 | |
| Domain | ACTINS_2 | 7.21e-04 | 17 | 44 | 2 | PS00432 | |
| Domain | PCI | 7.21e-04 | 17 | 44 | 2 | PF01399 | |
| Domain | PCI_dom | 7.21e-04 | 17 | 44 | 2 | IPR000717 | |
| Domain | Actin/actin-like_CS | 8.10e-04 | 18 | 44 | 2 | IPR020902 | |
| Domain | PDEase | 9.04e-04 | 19 | 44 | 2 | IPR023088 | |
| Domain | ACTINS_ACT_LIKE | 9.04e-04 | 19 | 44 | 2 | PS01132 | |
| Domain | PDEase_I | 1.11e-03 | 21 | 44 | 2 | PF00233 | |
| Domain | PDEASE_I | 1.11e-03 | 21 | 44 | 2 | PS00126 | |
| Domain | PDEase_CS | 1.11e-03 | 21 | 44 | 2 | IPR023174 | |
| Domain | - | 1.22e-03 | 22 | 44 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.33e-03 | 23 | 44 | 2 | IPR002073 | |
| Domain | HDc | 1.45e-03 | 24 | 44 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 1.45e-03 | 24 | 44 | 2 | IPR003607 | |
| Domain | SH3 | 1.64e-03 | 216 | 44 | 4 | PS50002 | |
| Domain | SH3 | 1.64e-03 | 216 | 44 | 4 | SM00326 | |
| Domain | SH3_domain | 1.76e-03 | 220 | 44 | 4 | IPR001452 | |
| Domain | ArfGap | 2.11e-03 | 29 | 44 | 2 | SM00105 | |
| Domain | ARFGAP | 2.11e-03 | 29 | 44 | 2 | PS50115 | |
| Domain | ArfGAP | 2.11e-03 | 29 | 44 | 2 | IPR001164 | |
| Domain | ArfGap | 2.11e-03 | 29 | 44 | 2 | PF01412 | |
| Domain | - | 2.18e-03 | 391 | 44 | 5 | 2.30.29.30 | |
| Domain | - | 2.26e-03 | 30 | 44 | 2 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 2.26e-03 | 30 | 44 | 2 | IPR027267 | |
| Domain | Actin | 2.42e-03 | 31 | 44 | 2 | IPR004000 | |
| Domain | Actin | 2.42e-03 | 31 | 44 | 2 | PF00022 | |
| Domain | ACTIN | 2.42e-03 | 31 | 44 | 2 | SM00268 | |
| Domain | PH_dom-like | 3.15e-03 | 426 | 44 | 5 | IPR011993 | |
| Domain | Ankyrin_rpt | 3.31e-03 | 262 | 44 | 4 | IPR002110 | |
| Domain | RGS | 3.80e-03 | 39 | 44 | 2 | IPR016137 | |
| Domain | TPR_8 | 6.93e-03 | 53 | 44 | 2 | PF13181 | |
| Domain | KRAB | 9.86e-03 | 358 | 44 | 4 | PF01352 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 1.64e-06 | 96 | 30 | 5 | M16121 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 3.12e-06 | 14 | 30 | 3 | M10122 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 4.18e-06 | 116 | 30 | 5 | MM14855 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 6.28e-06 | 126 | 30 | 5 | M705 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.23e-05 | 68 | 30 | 4 | MM14968 | |
| Pathway | KEGG_ENDOCYTOSIS | 3.63e-05 | 181 | 30 | 5 | M1519 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 6.44e-05 | 37 | 30 | 3 | MM15102 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 9.47e-05 | 719 | 30 | 8 | MM14540 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.19e-04 | 121 | 30 | 4 | M872 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.50e-04 | 49 | 30 | 3 | M891 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 1.69e-04 | 51 | 30 | 3 | M39457 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.04e-04 | 261 | 30 | 5 | MM15676 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 2.38e-04 | 11 | 30 | 2 | MM14732 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 2.52e-04 | 828 | 30 | 8 | M1058 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 2.85e-04 | 12 | 30 | 2 | M15243 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 3.08e-04 | 155 | 30 | 4 | MM14665 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_CASCADES | 4.38e-04 | 170 | 30 | 4 | M7494 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.70e-04 | 72 | 30 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.89e-04 | 73 | 30 | 3 | MM15906 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 8.65e-04 | 995 | 30 | 8 | MM14661 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 9.61e-04 | 92 | 30 | 3 | M27201 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.15e-03 | 575 | 30 | 6 | M29853 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.49e-03 | 27 | 30 | 2 | M47755 | |
| Pathway | REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 1.65e-03 | 111 | 30 | 3 | M27609 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 1.87e-03 | 116 | 30 | 3 | M2164 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.95e-03 | 1128 | 30 | 8 | M1036 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 2.09e-03 | 32 | 30 | 2 | M165 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE | 2.16e-03 | 122 | 30 | 3 | MM14640 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 2.22e-03 | 33 | 30 | 2 | M240 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 2.64e-03 | 36 | 30 | 2 | M39569 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 2.83e-03 | 134 | 30 | 3 | M3574 | |
| Pubmed | 1.56e-21 | 21 | 46 | 9 | 12216073 | ||
| Pubmed | 1.58e-19 | 9 | 46 | 7 | 14611804 | ||
| Pubmed | 1.81e-13 | 8 | 46 | 5 | 12007189 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 12383797 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 24273169 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 12511974 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 2.17e-09 | 3 | 46 | 3 | 28395327 | |
| Pubmed | SSX2-4 expression in early-stage non-small cell lung cancer. | 2.17e-09 | 3 | 46 | 3 | 24645645 | |
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 2.17e-09 | 3 | 46 | 3 | 24046449 | |
| Pubmed | 2.83e-09 | 407 | 46 | 9 | 15772651 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 8.65e-09 | 4 | 46 | 3 | 21689597 | |
| Pubmed | Expressions of cancer-testis antigens in human hepatocellular carcinomas. | 8.65e-09 | 4 | 46 | 3 | 11179834 | |
| Pubmed | 8.65e-09 | 4 | 46 | 3 | 22846998 | ||
| Pubmed | Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. | 8.65e-09 | 4 | 46 | 3 | 12037676 | |
| Pubmed | Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. | 8.65e-09 | 4 | 46 | 3 | 10749136 | |
| Pubmed | Molecular mechanisms underlying human synovial sarcoma development. | 8.65e-09 | 4 | 46 | 3 | 11107170 | |
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 9722593 | ||
| Pubmed | SSX: a multigene family with several members transcribed in normal testis and human cancer. | 2.16e-08 | 5 | 46 | 3 | 9378559 | |
| Pubmed | 4.32e-08 | 6 | 46 | 3 | 23640057 | ||
| Pubmed | 4.32e-08 | 6 | 46 | 3 | 27251629 | ||
| Pubmed | 4.32e-08 | 6 | 46 | 3 | 18602423 | ||
| Pubmed | 7.55e-08 | 7 | 46 | 3 | 15252009 | ||
| Pubmed | 1.21e-07 | 8 | 46 | 3 | 24282027 | ||
| Pubmed | 1.81e-07 | 9 | 46 | 3 | 23170932 | ||
| Pubmed | Dynamin genes Dnm1 and Dnm2 are located on proximal mouse chromosomes 2 and 9, respectively. | 1.81e-07 | 9 | 46 | 3 | 9143510 | |
| Pubmed | 2.58e-07 | 10 | 46 | 3 | 10398046 | ||
| Pubmed | 2.58e-07 | 10 | 46 | 3 | 23746204 | ||
| Pubmed | Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. | 7.80e-07 | 14 | 46 | 3 | 20802490 | |
| Pubmed | 1.37e-06 | 266 | 46 | 6 | 19380743 | ||
| Pubmed | 1.45e-06 | 17 | 46 | 3 | 37042948 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24710929 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16546222 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24673776 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 21670293 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16028072 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22977254 | ||
| Pubmed | A novel fluorescence in situ hybridization assay for synovial sarcoma. | 1.71e-06 | 2 | 46 | 2 | 23623359 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 1.71e-06 | 2 | 46 | 2 | 36157221 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20700106 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 7696711 | ||
| Pubmed | Dynamin is primed at endocytic sites for ultrafast endocytosis. | 1.71e-06 | 2 | 46 | 2 | 35809574 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 38641407 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15735574 | ||
| Pubmed | Dynamin-mediated lipid acquisition is essential for Chlamydia trachomatis development. | 1.71e-06 | 2 | 46 | 2 | 25116793 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 34274446 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 31879982 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11782545 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24963135 | ||
| Pubmed | [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma]. | 1.71e-06 | 2 | 46 | 2 | 22393780 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22898815 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26302298 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22308498 | ||
| Pubmed | Dynamin 2-dependent endocytosis is essential for mouse oocyte development and fertility. | 1.71e-06 | 2 | 46 | 2 | 32065700 | |
| Pubmed | An intramolecular signaling element that modulates dynamin function in vitro and in vivo. | 1.71e-06 | 2 | 46 | 2 | 19515832 | |
| Pubmed | ASAP3 is a focal adhesion-associated Arf GAP that functions in cell migration and invasion. | 1.71e-06 | 2 | 46 | 2 | 18400762 | |
| Pubmed | 3.86e-06 | 497 | 46 | 7 | 23414517 | ||
| Pubmed | 4.12e-06 | 322 | 46 | 6 | 26514267 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 22371560 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 7539744 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 23936390 | ||
| Pubmed | ACAP4 interacts with CrkII to promote the recycling of integrin β1. | 5.13e-06 | 3 | 46 | 2 | 31182282 | |
| Pubmed | Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. | 5.13e-06 | 3 | 46 | 2 | 15895076 | |
| Pubmed | Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases. | 5.13e-06 | 3 | 46 | 2 | 22976541 | |
| Pubmed | Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9. | 5.13e-06 | 3 | 46 | 2 | 35065714 | |
| Pubmed | SNX9 regulates dynamin assembly and is required for efficient clathrin-mediated endocytosis. | 5.13e-06 | 3 | 46 | 2 | 15703209 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 19617714 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 24130893 | ||
| Pubmed | Lipid droplet breakdown requires dynamin 2 for vesiculation of autolysosomal tubules in hepatocytes. | 5.13e-06 | 3 | 46 | 2 | 24145164 | |
| Pubmed | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 5.13e-06 | 3 | 46 | 2 | 32573516 | |
| Pubmed | The Eps15 C. elegans homologue EHS-1 is implicated in synaptic vesicle recycling. | 5.13e-06 | 3 | 46 | 2 | 11483962 | |
| Pubmed | Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. | 5.13e-06 | 3 | 46 | 2 | 18462748 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 18707587 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 22027826 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 7655467 | ||
| Pubmed | Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. | 5.13e-06 | 3 | 46 | 2 | 16152617 | |
| Pubmed | SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma. | 5.13e-06 | 3 | 46 | 2 | 24166495 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 6.02e-06 | 344 | 46 | 6 | 30333137 | |
| Pubmed | 6.19e-06 | 27 | 46 | 3 | 18685082 | ||
| Pubmed | 6.19e-06 | 27 | 46 | 3 | 19723784 | ||
| Pubmed | 7.65e-06 | 552 | 46 | 7 | 36293380 | ||
| Pubmed | Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. | 1.03e-05 | 4 | 46 | 2 | 20059951 | |
| Pubmed | miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1. | 1.03e-05 | 4 | 46 | 2 | 27499367 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 28621662 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 23033484 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 24611815 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 10504338 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 20133364 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 21799013 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 24706882 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 11368913 | ||
| Pubmed | Dynamin2 and cortactin regulate actin assembly and filament organization. | 1.03e-05 | 4 | 46 | 2 | 12419186 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 14709338 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 7951320 | ||
| Pubmed | Dynamin and endocytosis are required for the fusion of osteoclasts and myoblasts. | 1.03e-05 | 4 | 46 | 2 | 25287300 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 22734003 | ||
| Pubmed | 1.08e-05 | 103 | 46 | 4 | 21706016 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 21169560 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 22349830 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 19469865 | ||
| Interaction | SSX2 interactions | 6.69e-10 | 45 | 45 | 6 | int:SSX2 | |
| Interaction | PACSIN3 interactions | 1.54e-08 | 131 | 45 | 7 | int:PACSIN3 | |
| Interaction | SSX2B interactions | 1.23e-06 | 10 | 45 | 3 | int:SSX2B | |
| Interaction | SH3GL2 interactions | 1.51e-06 | 88 | 45 | 5 | int:SH3GL2 | |
| Interaction | SSX7 interactions | 1.70e-06 | 11 | 45 | 3 | int:SSX7 | |
| Interaction | PACSIN1 interactions | 9.65e-06 | 60 | 45 | 4 | int:PACSIN1 | |
| Interaction | TPM1 interactions | 2.48e-05 | 263 | 45 | 6 | int:TPM1 | |
| Interaction | ITGB3 interactions | 3.74e-05 | 170 | 45 | 5 | int:ITGB3 | |
| Interaction | MYOM2 interactions | 4.48e-05 | 31 | 45 | 3 | int:MYOM2 | |
| Interaction | ZBBX interactions | 4.48e-05 | 31 | 45 | 3 | int:ZBBX | |
| Interaction | LYPD6 interactions | 5.42e-05 | 33 | 45 | 3 | int:LYPD6 | |
| Interaction | PACSIN2 interactions | 5.60e-05 | 185 | 45 | 5 | int:PACSIN2 | |
| Interaction | FLACC1 interactions | 5.93e-05 | 34 | 45 | 3 | int:FLACC1 | |
| Interaction | BSG interactions | 6.84e-05 | 631 | 45 | 8 | int:BSG | |
| Interaction | SSX3 interactions | 7.05e-05 | 36 | 45 | 3 | int:SSX3 | |
| Interaction | SSX6P interactions | 1.35e-04 | 8 | 45 | 2 | int:SSX6P | |
| Interaction | CRKL interactions | 1.47e-04 | 227 | 45 | 5 | int:CRKL | |
| Interaction | SSX4 interactions | 1.74e-04 | 9 | 45 | 2 | int:SSX4 | |
| Interaction | FER interactions | 1.89e-04 | 50 | 45 | 3 | int:FER | |
| Interaction | FNBP1 interactions | 2.07e-04 | 131 | 45 | 4 | int:FNBP1 | |
| Interaction | VCP interactions | DNM3 SERPINB1 ACTR1A CILK1 HSP90B1 MYH9 NEB USP48 ITGB1 DNM2 EIF3CL | 2.44e-04 | 1435 | 45 | 11 | int:VCP |
| Interaction | TEX101 interactions | 2.52e-04 | 255 | 45 | 5 | int:TEX101 | |
| Interaction | SSX5 interactions | 2.65e-04 | 11 | 45 | 2 | int:SSX5 | |
| Interaction | PDE6A interactions | 2.65e-04 | 11 | 45 | 2 | int:PDE6A | |
| Interaction | RPE interactions | 2.95e-04 | 58 | 45 | 3 | int:RPE | |
| Interaction | ACTR1A interactions | 3.51e-04 | 274 | 45 | 5 | int:ACTR1A | |
| Interaction | POSTN interactions | 3.74e-04 | 13 | 45 | 2 | int:POSTN | |
| Interaction | SNX33 interactions | 3.94e-04 | 64 | 45 | 3 | int:SNX33 | |
| Interaction | DNM1 interactions | 4.22e-04 | 158 | 45 | 4 | int:DNM1 | |
| Interaction | PDE6C interactions | 4.36e-04 | 14 | 45 | 2 | int:PDE6C | |
| Interaction | MMP9 interactions | 4.51e-04 | 67 | 45 | 3 | int:MMP9 | |
| Cytoband | Xp11.23 | 6.50e-12 | 95 | 46 | 7 | Xp11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 1.30e-10 | 377 | 46 | 9 | chrXp11 | |
| Cytoband | 1q25 | 3.14e-04 | 26 | 46 | 2 | 1q25 | |
| Cytoband | 1p36.12 | 7.11e-04 | 39 | 46 | 2 | 1p36.12 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.52e-06 | 206 | 24 | 5 | 682 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.27e-04 | 17 | 24 | 2 | 1291 | |
| GeneFamily | Phosphodiesterases | 4.58e-04 | 24 | 24 | 2 | 681 | |
| GeneFamily | ArfGAPs | 8.70e-04 | 33 | 24 | 2 | 395 | |
| GeneFamily | Ankyrin repeat domain containing | 3.89e-03 | 242 | 24 | 3 | 403 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.01e-02 | 115 | 24 | 2 | 769 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 | 8.80e-08 | 6 | 44 | 3 | M5931 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.28e-06 | 208 | 44 | 6 | MM581 | |
| Coexpression | HELLER_SILENCED_BY_METHYLATION_UP | 7.51e-06 | 283 | 44 | 6 | M8776 | |
| Coexpression | ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP | 1.48e-05 | 186 | 44 | 5 | M3019 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP | 1.52e-05 | 89 | 44 | 4 | M2761 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.42e-05 | 206 | 44 | 5 | M2817 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 3.57e-05 | 38 | 44 | 3 | M39244 | |
| Coexpression | MUELLER_METHYLATED_IN_GLIOBLASTOMA | 5.20e-05 | 43 | 44 | 3 | M912 | |
| Coexpression | KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP | 8.01e-05 | 136 | 44 | 4 | M126 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 1.11e-04 | 458 | 44 | 6 | M40010 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 1.48e-04 | 302 | 44 | 5 | MM16604 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 1.71e-04 | 64 | 44 | 3 | MM671 | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.58e-05 | 166 | 46 | 4 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 170 | 46 | 4 | 2b5b1f8d13b9806b76b44a53f47a23dd9ff09808 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 170 | 46 | 4 | 43c48267d8291c88263148a36fbb63c27f0e4f1c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.95e-05 | 185 | 46 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-05 | 186 | 46 | 4 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 191 | 46 | 4 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 193 | 46 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 193 | 46 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 193 | 46 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 193 | 46 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 4.94e-05 | 196 | 46 | 4 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-05 | 198 | 46 | 4 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.24e-05 | 199 | 46 | 4 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.24e-05 | 199 | 46 | 4 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 46 | 4 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 46 | 4 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 200 | 46 | 4 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 200 | 46 | 4 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| Drug | 2d41 | 2.10e-09 | 27 | 46 | 5 | CID009543496 | |
| Drug | DB01888 | 5.53e-08 | 19 | 46 | 4 | CID005287990 | |
| Drug | auxin | 3.14e-07 | 224 | 46 | 7 | CID000000801 | |
| Drug | Go7874 | 1.68e-06 | 12 | 46 | 3 | CID005327863 | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; PC3; HT_HG-U133A | 2.73e-06 | 197 | 46 | 6 | 4079_DN | |
| Drug | library 2 | 7.31e-06 | 19 | 46 | 3 | CID005270634 | |
| Drug | DB04649 | 1.20e-05 | 148 | 46 | 5 | CID005287847 | |
| Drug | AC1L9JXQ | 4.04e-05 | 33 | 46 | 3 | CID000446658 | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; HL60; HG-U133A | 4.19e-05 | 192 | 46 | 5 | 1419_DN | |
| Drug | AC1L1KMJ | 4.42e-05 | 476 | 46 | 7 | CID000030956 | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; HL60; HT_HG-U133A | 4.51e-05 | 195 | 46 | 5 | 2719_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 4318_DN | |
| Drug | AC1OAGGW | 5.46e-05 | 203 | 46 | 5 | CID006857364 | |
| Drug | 5-(N,N-hexamethylene)amiloride | 5.96e-05 | 6 | 46 | 2 | ctd:C057360 | |
| Drug | blebbistatin | 8.85e-05 | 116 | 46 | 4 | CID003476986 | |
| Drug | AC1OAGFB | 9.64e-05 | 539 | 46 | 7 | CID006857345 | |
| Drug | TCNB | 9.77e-05 | 119 | 46 | 4 | CID000008330 | |
| Drug | 2gzl | 1.10e-04 | 46 | 46 | 3 | CID006102719 | |
| Drug | blebbistatin | 1.11e-04 | 8 | 46 | 2 | ctd:C472645 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 2.13e-08 | 5 | 39 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 2.13e-08 | 5 | 39 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 2.13e-08 | 5 | 39 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 4.66e-07 | 12 | 39 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 6.05e-07 | 13 | 39 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.54e-05 | 43 | 39 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | synovial sarcoma | 2.54e-05 | 6 | 39 | 2 | C0039101 | |
| Disease | Nemaline Myopathy, Childhood Onset | 3.56e-05 | 7 | 39 | 2 | C0546125 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 4.74e-05 | 8 | 39 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 2.29e-04 | 17 | 39 | 2 | DOID:11984 (is_marker_for) | |
| Disease | lifestyle measurement, depressive symptom measurement | 3.65e-04 | 105 | 39 | 3 | EFO_0007006, EFO_0010724 | |
| Disease | response to risperidone | 1.16e-03 | 38 | 39 | 2 | GO_0097336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NDEEMKAAKEKLKYW | 511 | O95696 | |
| QLEKAWKDYEAKMAK | 146 | Q8TDY4 | |
| WKDYEAKMAKLEKER | 151 | Q8TDY4 | |
| KTKIDAENDKEWMLY | 1351 | Q9NXG0 | |
| DTFKKMWVSKKEYEE | 351 | P42025 | |
| IEEKEFTEWNKKFMA | 661 | O43520 | |
| DKFWRYNEVKKKMDP | 586 | P08253 | |
| REFAKFEKEKMNAKW | 761 | P05556 | |
| RFLKDAMWKKDKKDF | 261 | Q8N9V6 | |
| NIAFMYAKKEEWKKA | 126 | P19878 | |
| DSIYDEMEEKWSKQK | 226 | Q96Q35 | |
| SWYKDDEEKEKKYML | 551 | Q05193 | |
| KKEIEKAWKMVDSAY | 96 | Q5T655 | |
| KAWKMVDSAYDKEQK | 101 | Q5T655 | |
| LSWYKDDEEKEKKYM | 556 | Q9UQ16 | |
| RKEWKALADEYDAKM | 806 | P16499 | |
| EWKSLADEYDAKMKV | 811 | P51160 | |
| YEDDKKEWAGMLKEI | 571 | O60662 | |
| EKKDDFDWGKYLMED | 136 | Q96RT8 | |
| KVDYKADEWLMKNMD | 576 | P35579 | |
| SWYKDEEEKEKKYML | 551 | P50570 | |
| KMNDELYKEEKIWKE | 231 | Q96JM4 | |
| MIKKIADDKYNDTFW | 471 | P14625 | |
| YLNELWEDKEGKKKM | 116 | Q99613 | |
| YLNELWEDKEGKKKM | 116 | B5ME19 | |
| SYFDKGKMWEKAIKL | 1306 | Q9H7D0 | |
| DTFKKMWVSKKEYEE | 351 | P61163 | |
| FDKAWKDYETKFTKI | 166 | Q9ULH1 | |
| YFKGNWKDKFMKEAT | 166 | P30740 | |
| VTTDEWKKVFYEKME | 41 | P59025 | |
| WKKVFYEKMEEAKPA | 46 | P59025 | |
| MKSIEEKWFKDYQDL | 741 | A5PLK6 | |
| DDIAKYFSKEEWEKM | 26 | Q99909 | |
| YFSKEEWEKMKVSEK | 31 | Q99909 | |
| DDIATYFSKKEWKKM | 26 | Q16384 | |
| AIKKMKRKFYSWEEC | 31 | Q9UPZ9 | |
| DDIAKYFSKEEWEKM | 26 | Q16385 | |
| YFSKEEWEKMKASEK | 31 | Q16385 | |
| DDIAKYFSKKEWEKM | 26 | O60224 | |
| YFSKKEWEKMKSSEK | 31 | O60224 | |
| EWEKMKSSEKIVYVY | 36 | O60224 | |
| DDIAKYFSEKEWEKM | 26 | O60225 | |
| YFSEKEWEKMKASEK | 31 | O60225 | |
| DDIAKYFSKEEWEKM | 26 | Q7RTT6 | |
| YFSKEEWEKMKFSEK | 31 | Q7RTT6 | |
| DDIAKYFSKKEWEKM | 26 | Q7RTT5 | |
| YFSKKEWEKMKSLEK | 31 | Q7RTT5 | |
| EWEKMKSLEKISYVY | 36 | Q7RTT5 | |
| NDIATYFSKKEWEKM | 26 | Q7RTT4 | |
| YFSKKEWEKMKYSEK | 31 | Q7RTT4 | |
| DDIAKYFSKKEWEKM | 26 | Q7RTT3 | |
| YFSKKEWEKMKSSEK | 31 | Q7RTT3 | |
| LDAKFNADKFKWDKM | 436 | Q9P2N2 | |
| KEALLWYSEAMKLDK | 351 | Q8NDW8 | |
| MSYSVKWKKSDVKFE | 191 | Q9HD45 | |
| WYKFNDEDIEKMEGK | 366 | Q86UV5 | |
| KMVKTYLEEELDKWA | 81 | Q16719 | |
| WLDQKEDDKKYMKSL | 86 | Q5VVJ2 | |
| MFSKKLYTEDWEADK | 201 | P20929 | |
| DREYKKDFEKWKTKF | 2586 | P20929 | |
| EYKKDFEKWKTKFSS | 2831 | P20929 | |
| SDREYKKDFEKWKTK | 3071 | P20929 |